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In a previous study, we generated transmitochondrial P29mtSAMP1 cybrids, which had nuclear DNA
from the C57BL6 (referred to as B6) mouse strain-derived P29 tumor cells and mitochondrial DNA
(mtDNA) exogenously-transferred from the allogeneic strain SAMP1. Because P29mtSAMP1 cybrids did
not form tumors in syngeneic B6 mice, we proposed that allogeneic SAMP1 mtDNA suppressed tumor
formation of P29mtSAMP1 cybrids. To test this hypothesis, current study generated P29mt(sp)B6 cybrids
carrying all genomes (nuclear DNA and mtDNA) from syngeneic B6 mice by eliminating SAMP1 mtDNA
from P29mtSAMP1 cybrids and reintroducing B6 mtDNA. However, the P29mt(sp)B6 cybrids did not
form tumors in B6 mice, even though they had no SAMP1 mtDNA, suggesting that SAMP1 mtDNA is not
involved in tumor suppression. Then, we examined another possibility of whether SAMP1 mtDNA
fragments potentially integrated into the nuclear DNA of P29mtSAMP1 cybrids are responsible for tumor
suppression. We generated P29H(sp)B6 cybrids by eliminating nuclear DNA from P29mt(sp)B6 cybrids
and reintroducing nuclear DNA with no integrated SAMP1 mtDNA fragment from mtDNA-less P29 cells
resistant to hygromycin in selection medium containing hygromycin. However, the P29H(sp)B6 cybrids
did not form tumors in B6 mice, even though they carried neither SAMP1 mtDNA nor nuclear DNA with
integrated SAMP1 mtDNA fragments. Moreover, overproduction of reactive oxygen species (ROS) and
bacterial infection were not involved in tumor suppression. These observations suggest that tumor
suppression was caused not by mtDNA with polymorphic mutations or infection of cytozoic bacteria but
by hypothetical heritable cytoplasmic elements other than mtDNA from SAMP1 mice.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mammalian mtDNA with pathogenic mutations, which induce
mitochondrial respiration defects, could be responsible not only for
mitochondrial diseases [1e6], but also for aging and age-associated
disorders including tumor formation [1e3,7e9]. However, we have
shown that age-associated respiration defects in human ﬁbroblastsshi).
r Inc. This is an open access articloccur not because of pathogenic mtDNA mutations or the resultant
ROS overproduction [10,11], but because of reversible epigenetic
changes of nuclear genes [12,13].
With respect to the tumor formation, mtDNA with pathogenic
mutations has been proposed to function as a tumor enhancer
because of its induction of the respiration defects and the resultant
enhanced glycolysis under normoxic conditions (the Warburg ef-
fect) [9]. This concept has been supported by our previous ﬁndings
that mouse mtDNA with a pathogenic mutation that simulta-
neously induces respiration defects and ROS overproduction func-
tions as a tumor enhancer [14,15].e under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tions, which do not induce respiration defects, has been shown to
function as a tumor suppressor rather than a tumor enhancer
[16e18]. For example, mtDNA from allogeneic mouse strains has
many polymorphic mutations, and transmitochondrial P29mtNZB
cybrids (generated by replacing mtDNA in P29 tumor cells derived
from the C57BL6 mouse strain [hereafter referred to as B6] with
mtDNA from the allogeneic strain NZB) are unable to form tumors
in B6 mice because of the recognition of these cybrids by B6 innate
immune cells [18]. To generalize this idea, our subsequent studies
[19,20] generated transmitochondrial P29mtC3H cybrids [19] and
P29mtSAMP1 cybrids [20] with mtDNA derived from the allogeneic
strains C3H and SAMP1, respectively. P29mtC3H cybrids formed
tumors in B6mice [19], whereas the ability of P29mtSAMP1 cybrids
to form tumors in B6 mice was completely suppressed because of
their recognition by B6 innate immune cells [20]. On the basis of
these observations, we have proposed that the innate immune
system recognizes polymorphic mutations in mtDNA fromNZB and
SAMP1 mice but not from C3H mice [18,20].
However, it remains unclear which polypeptides encoded by
mtDNA are recognized by the innate immune cells of B6 mice, if
mtDNA from allogeneic strains is responsible for tumor suppres-
sion. It is also possible that some nuclear-encoded polypeptides
denatured by SAMP1 mtDNAeinduced ROS are recognized by
innate immune cells. To address these issues, we replaced alloge-
neic SAMP1 mtDNA in P29mtSAMP1 cybrids with syngeneic B6
mtDNA, and showed that neither SAMP1 mtDNAeencoded poly-
peptides nor SAMP1 mtDNAeinduced ROS overproduction is
responsible for tumor suppression of P29mtSAMP1 cybrids in B6
mice.
2. Materials and methods
2.1. Ethics statement
All animal experiments were performed in accordance with
protocols approved by the Institutional Animal Care and Use
Committee of University of Tsukuba, Japan (Permit Number:
15314).
2.2. Cell lines and cell culture
The P29 cells are B6 mouseederived Lewis lung carcinoma cells
[21]. Transmitochondrial cybrids (P29mtB6 and P29mtSAMP1)
were established in our previous study [20; Fig. S1A] by isolation of
mtDNA-less (r0) P29 cells. Both P29mtB6 and P29mtSAMP1cybrids
had nuclear DNA from r0P29 cells and mtDNA from B6 mice
(P29mtB6) or SAMP1 mice (P29mtSAMP1). All cells were grown in
DMEM (Sigma, St. Louis, MO, USA) containing 10% fetal calf serum
(Sanko Junyaku, Tokyo, Japan), 50 mg/ml uridine (Sigma, St. Louis,
MO, USA), and 0.1 mg/ml sodium pyruvate (Wako Pure Chemical
Industries, Osaka, Japan).
2.3. Isolation of r0 P29mt(b6) cells, r0 P29mt(sp) cells, and r0 P29H
cells
To obtain r0 P29mt(b6) cells and r0 P29mt(sp) cells, P29mtB6
and P29mtSAMP1cybrids [20], respectively, were treated with
1.5 mg/ml ditercalinium, an antitumor bis-intercalating agent [22],
for 1 week, and mtDNA eliminationwas conﬁrmed by PCR analysis.
To obtain hygromycin-resistant (Hyg-R) r0 P29 cells (r0 P29H cells),
r0 P29 cells [20] were transfected with a Hyg-R plasmid (pTK-Hyg
Vector; Clontech Laboratories, Mountain View CA, USA) and culti-
vated in the presence of hygromycin (200 mg/ml) for 2 weeks.2.4. Isolation of new transmitochondrial cybrids
To obtain P29mt(b6)B6 and P29mt(sp)B6 cybrids, nuclear do-
nors (r0 P29mt(b6) or r0 P29mt(sp) cells) and mtDNA donors
(platelets from B6 mice) were fused the presence of polyethylene
glycol (polyethylene glycol 1500; Roche, Basel, Switzerland); un-
fused nuclear donor cells were eliminated in selection medium
without uridine and sodium pyruvate (UP-)(Table 1, Fig. S1A).
To obtain P29Hmt(b6)B6 and P29Hmt(sp)B6 cybrids, nuclear
donors (r0 P29H cells) and mtDNA donors (enucleated P29mt(b6)
B6 or P29mt(sp)B6 cybrids) were fused; unfused nuclear donor
cells and unenucleated mtDNA donor cells were eliminated in UP-
selection medium with hygromycin (Table 2, Fig. S1B).
2.5. Genotyping of B6 mtDNA and Hyg-R nuclear DNA in the
cybrids
To distinguish between B6 mtDNA and SAMP1 mtDNA, we used
a polymorphic mutation (A11181G) in the ND4 gene (encoding
NADH dehydrogenase subunit 4) of SAMP1 mtDNA [19]. Brieﬂy, a
194-bp fragment containing the 11181 site was ampliﬁed by PCR
with the primers AAC AAT ACT AAT AAT CGC ACA TGG (nucleotide
positions: 11,102e11,125) and CTA TTA GAT TGA TTG AAG GGG GTA
(11,295e11,272). SAMP1 mtDNA has an EagI restriction site (EagI
cleavage produces 115-bp and 79-bp fragments), whereas B6
mtDNA has no EagI site and generates a 194-bp fragment. The size
of the fragments was analysed in a 3% agarose gel [19].
To detect the Hyg-R plasmid in r0 P29H cells, P29Hmt(b6)B6
cybrids, and P29Hmt(sp)B6 cybrids, we used primers GAT GTA GGA
GGG CGT GGA TA (nucleotide positions 118e137 in the coding
sequence of the hygromycin B phosphotransferase gene) and ATA
GGT CAG GCT CTC GCT GA (267e248).
2.6. Measurement of mitochondrial ROS
Generation of mitochondrial ROS (superoxide) was quantiﬁed
by using the mitochondrial superoxide indicator MitoSOX-Red
(Invitrogen, Carlsbad, CA, USA) as reported previously [14].
Brieﬂy, cells were mildly trypsinized and suspended in PBS
(1  105 cells/ml). The cells were then incubated with 5 mM
MitoSOX-Red for 15 min at 37 C in PBS, washed twice with PBS,
and analyzed with a FACS calibur (Becton Dickinson, Mountain
View, CA, USA). Datawere analyzedwith FlowJo software (Tree Star,
Ashland, OR, USA).
2.7. Assays of tumor formation
Tumor formation was examined by subcutaneous inoculation of
5  106 cells in 100 ml PBS into the back of 6-weekeold male B6
mice, which were obtained from CLEA (Tokyo, Japan). The growth
of tumors was monitored assuming their spherical shape [20].
When a tumor mass was visually detectable, its maximum (a) and
minimum (b) diameters and height (h) were recorded every 5 days.
The volume of each tumor was calculated as V ¼ pabh/6. The
recipient mice were euthanized by cervical dislocation when the
tumor volume reached 500 mm3.
2.8. Examination of bacterial infection in transmitochondrial
cybrids
To examine whether transmitochondrial cybrids might be infec-
ted with bacteria, we used PCR to detect bacterial 16S rRNA genes.
Total genomicDNAwasextracted fromeach cybrid linewith aGentra
Puregene Cell Kit (Qiagen, Hilden, Germany) and used in PCR with
Takara Ex Taq (Takara Bio, Shiga, Japan) and a primer pair designed to
Table 1
Genetic characteristics of cells, fusion combinations, and obtained transmitochondrial cybrids with B6 mtDNA.
Cells Mouse strain Fusion combination Selection
Nuclear DNA mtDNA Nuclear donor  mtDNA donor
Parent cells
(nuclear donors)
r0 P29mt(b6) cellsa B6 e
r0 P29mt(sp) cellsa B6 e
(mtDNA donors)
B6 platelets e B6
Cybrids
P29mt(b6)B6 B6 B6 r0 P29(b6) cells  B6 platelets UP-b
P29mt(sp)B6 B6 B6 r0 P29(sp) cells  B6 platelets UP-b
a r0 P29mt(b6) cells and r0 P29mt(sp) cells were obtained from P29mtB6 cybrids with B6 mtDNA and P29mtSAMP1 cybrids with SAMP1 mtDNA, respectively, by complete
depletion of their own mtDNA.
b For selective isolation of P29mt(b6)B6 and P29mt(sp)B6 cybrids, we used the selection mediumwithout uridine and sodium pyruvate (UP-) to exclude unfused r0 P29(b6)
and r0 P29(sp) cells, which do not survive without uridine and sodium pyruvate because of mtDNA depletion.
Table 2
Genetic characteristics of cells, fusion combinations, and obtained transmitochondrial cybrids with nuclear DNA from r0 P29H cells.
Cells Mouse strains Fusion combination Selection
Nuclear DNA mtDNA Nuclear donor  mtDNA donor
Parent cells
(nuclear donors)
r0 P29H cellsa B6, Hyg-R e
(mtDNA donors)
enP29mt(b6)B6b e B6
enP29mt(sp)B6b e B6
Cybrids
P29Hmt(b6)B6 B6, Hyg-R B6 r0 P29H cellsa  enP29mt(b6)B6b UP-, Hyg
P29Hmt(sp)B6 B6, Hyg-R B6 r0 P29H cellsa  enP29mt(sp)B6b UP-, Hyg
a r0 P29H cells were obtained from r0 P29 cells by transfection with the Hyg-R plasmid. r0 P29 cells were obtained in our previous study [11] by complete depletion of
mtDNA from P29 cells.
b enP29mt(b6)B6 and enP29mt(sp)B6 represent enucleated P29mt(b6)B6 and P29mt(sp)B6 cybrids, respectively. To obtain P29Hmt(b6)B6 and P29Hmt(sp)B6 cybrids, we
used selection medium with hygromycin and without uridine and sodium pyruvate (UP-): unenucleated cybrids were eliminated in the presence of hygromycin, whereas
unfused r0 P29H cells were eliminated in the absence of uridine and sodium pyruvate (UP-).
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sequences of the primers were based on the highly conserved 16S
rRNA gene sequence of Rickettsia prowazekii (GenBank accession no.
AJ235272): forwardAGAGTTTGATCCTGGCTCAG (nucleotides 17e36)
and reverse TAAGGAGGTGATCCAGCC (1507e1490). The PCR prod-
ucts were separated by 1% agarose gel electrophoresis, and DNA
bands of the expected length (~1500 bp) were extracted with a
FastGeneGel/PCRExtractionKit (NipponGenetics, Tokyo, Japan). The
puriﬁed DNA fragments were cloned into the pGEM vector using the
TAcloning reaction inaLigaFasRapidDNALigationSystem(Promega,
Fitchburg, WI, USA). The resultant plasmids were transformed into
E. coli, andwe performed screening on IPTG/Xgal plates.White E. coli
colonies were selected, and their DNAwas sequenced on an Applied
Biosystems 3130 Genetic Analyzer (Applied Biosystems, Foster City,
CA, USA). Each obtained sequencewas subjected to BLASTN search to
identify the PCR product.
2.9. Statistical analysis
All experiments were conducted at least three times. Differences
between groups of values were assessed by Dunnett's test. All
values are means ± S.D. P values < 0.05 were considered to be
statistically signiﬁcant.
3. Results
3.1. SAMP1 mtDNA is not involved in tumor suppression in B6 mice
Previously we proposed that polypeptides encoded by SAMP1mtDNA in P29mtSAMP1 cybrids are responsible for the suppression
of the ability of these cybrids to form tumors in B6mice [20]. To test
this hypothesis, in the current study we replaced the mtDNA of
P29mtSAMP1 cybrids with B6 mtDNA (Fig. S1A). First, we
completely excluded SAMP1 mtDNA from P29mtSAMP1 cybrids
and obtained mtDNA-less P29mtSAMP1 cybrids, named r0
P29mt(sp) cells. To introduce B6 mtDNA, we fused r0 P29mt(sp)
cells with platelets from B6 mice and isolated new trans-
mitochondrial P29mt(sp)B6 cybrids (Table 1).
As controls, we used P29mtB6 cybrids harboring both nuclear
DNA and mtDNA from the B6 strain, and isolated corresponding
mtDNA-less P29mtB6 cybrids, named r0 P29mt(b6) cells. We
reintroduced B6 mtDNA from platelets of B6 mice into r0
P29mt(b6) cells, and obtained new transmitochondrial P29mt(b6)
B6 cybrids (Table 1). Genotyping showed that P29mt(sp)B6 and
P29mt(b6)B6 cybrids had B6 mtDNA but not SAMP1 mtDNA
(Fig. 1A).
Then, we examined tumor formation in B6mice inoculated with
P29mt(sp)B6 or P29mt(b6)B6 cybrids. Even though both cybrids
had nuclear DNA and mtDNA from the B6 strain (Fig. S1A),
P29mt(b6)B6 but not P29mt(sp)B6 cybrids formed tumors (Fig. 1B).
These observations suggest that the suppression of tumor forma-
tion by P29mt(sp)B6 cybrids in B6 mice was not caused by SAMP1
mtDNA.3.2. Nuclear-integrated SAMP1 mtDNA fragments are not involved
in tumor suppression in B6 mice
Another possibility is that nuclear DNA in P29mtSAMP1 cybrids
Fig. 1. Effects of an mtDNA replacement of P29mtSAMP1 cybrids from SAMP1 to B6 on tumor formation. (A) mtDNA genotyping. The absence of mtDNA in r0 P29mt(b6) and r0
P29mt(sp) cells was conﬁrmed by the absence of its PCR products. To genotype mtDNA in the cybrids (see Fig. S1A), the PCR products of their mtDNA were digested with EagI. The
SAMP1 mtDNA, which has the A11181G mutation, produces 115-bp and 79-bp fragments due to the gain of an EagI site. B6 mtDNA has no such mutation and produces a 194-bp
fragment resistant to EagI digestion. All cybrids except P29mtSAMP1 had only B6 mtDNA. (B) P29mt(sp)B6 cybrids do not form tumors. Cells (5  106) were inoculated under the
skin of B6 mice. No tumors were formed by P29mt(sp)B6 cybrids for up to 3 months, whereas P29mt(b6)B6 cybrids formed tumors within 10 days after inoculation.
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sequences, NUMTs) [23,24] during cultivation, and that the prod-
ucts of NUMTs are translocated onto the cell surface, where they are
recognized by B6 innate immune cells to suppress tumor forma-
tion. In this case, SAMP1 mtDNAederived NUMTs could be trans-
ferred via r0 P29mt(sp) cells into P29mt(sp)B6 cybrids (Fig. S1A),
resulting in tumor suppression (Fig. 1B).
We examined this possibility by replacing the nuclear DNA of
P29mt(sp)B6 cybrids with nuclear DNA that does not contain
SAMP1 mtDNAederived NUMTs (Table 2, Fig. S1B). As nuclear do-
nors without SAMP1mtDNAederived NUMTs, we usedmtDNA-less
P29 cells (r0 P29 cells), which we isolated previously [11]. For se-
lection and identiﬁcation of the cells carrying nuclear DNA from r0
P29 cells, we generated Hyg-R r0 P29 cells (r0 P29H cells) by
transfecting r0 P29 cells with the Hyg-R plasmid. Then, we fused r0
P29H cells with enucleated P29mt(sp)B6 cybrids and used selection
medium with hygromycin and without uridine and pyruvate to
eliminate unenucleated P29mt(sp)B6 cybrids and unfused r0 P29H
cells, respectively. A colony that grew in the selection mediumwas
clonally isolated and named P29Hmt(sp)B6 cybrids (Table 2, Fig.
S1B). As a control, we also fused enucleated P29mt(b6)B6 cybrids
with r0 P29H cells in the same selection medium. A colony was
clonally isolated and named P29Hmt(b6)B6 cybrids (Table 2, Fig.
S1B).
Genotyping of mtDNA and nuclear DNA showed that both
P29Hmt(sp)B6 and P29Hmt(b6)B6 cybrids had B6 mtDNA (Fig. 2A)
and the Hyg-R plasmid (Fig. 2B), whereas P29mt(b6)B6 and
P29mt(sp)B6 cybrids had no Hyg-R plasmid (Fig. 2B). Thus, the
nuclear DNA of P29Hmt(sp)B6 and P29Hmt(b6)B6 cybrids had no
NUMTs derived from SAMP1 mtDNA (Fig. S1B).
To examine tumor formation by P29Hmt(b6)B6 and P29Hmt(sp)
B6 cybrids, we inoculated them under the skin of B6 mice.
P29Hmt(sp)B6 cybrids did not form tumors, whereas P29Hmt(b6)
B6 cybrids developed into tumors (Fig. 2C), even though both
cybrids harbored B6-derived nuclear DNA and B6-derived mtDNA
(Fig. S1B). Because nuclear donors (r0 P29H cells) had nuclear DNA
without NUMTs derived from SAMP1 mtDNA, we concluded that
tumor suppression was not caused by such NUMTs.3.3. ROS overproduction or bacterial infection is not involved in
tumor suppression
Previously we found a slight increase in the amounts of ROS
(superoxide) in P29mtSAMP1 cybrids compared to P29mtB6
cybrids [20]. In this study, we found no statistically signiﬁcant
difference in the amounts of ROS between P29Hmt(b6)B6 andP29Hmt(sp)B6 cybrids (Fig. 3), even though tumor formation only
by P29Hmt(sp)B6 cybrids was suppressed (Fig. 2C). These obser-
vations, together with the ﬁnding that replacement of SAMP1
mtDNA in P29mtSAMP1 cybrids with B6 mtDNA did not restore
tumor formation in B6 mice (Fig. 1), suggest that ROS over-
production induced by SAMP1 mtDNA is not involved in suppres-
sion of tumor formation.
We also examined a possible involvement of cytozoic bacteria
that might be transferred from SAMP1 mice to P29Hmt(sp)B6
cybrids; to detect such bacteria, we cloned and sequenced PCR
products potentially corresponding to the bacterial 16S rRNA gene.
BLAST searches showed that all seven sequenced PCR products
were derived from the mouse nuclear genome, not from bacterial
genomes (Table 3). These data indicate that tumor suppression is
not due to cytozoic bacteria.
Overall, the results of our current study suggest that heritable
cytoplasmic elements other than mtDNA and bacteria from SAMP1
mice are responsible for tumor suppression in B6 mice (Fig. S2).4. Discussion
In this study, we replaced SAMP1 mtDNA in P29mtSAMP1
cybrids with B6 mtDNA (Fig. S1A), and showed that the resultant
P29mt(sp)B6 cybrids did not regain tumor formation in B6 mice
(Fig. S2). Therefore, SAMP1 mtDNA does not suppress tumor for-
mation by P29mt(sp)B6 cybrids in B6 mice. Then, we replaced
nuclear DNA in P29mt(sp)B6 cybrids with that from r0 P29H cells,
which did not contain NUMTs derived from SAMP1 mtDNA (Fig.
S1B), and showed that the resultant P29Hmt(sp)B6 cybrids still
did not regain tumor formation in B6 mice (Fig. S2). Therefore,
neither SAMP1 mtDNA nor SAMP1 mtDNAederived fragments in
nuclear DNA suppresses tumor formation by P29mt(sp)B6 or
P29Hmt(sp)B6 cybrids.
It has been proposed that ROS overproduction promotes tumor
growth [25]. Our previous study [14] supported this idea by
showing that P29mtA11 cybrids with mtDNA from highly meta-
static lung carcinoma A11 cells had a high metastatic potential
because of A11 mtDNAemediated ROS overproduction. In contrast,
our recent study [20] indicated possible involvement of ROS over-
production caused by SAMP1 mtDNA in the suppression of tumor
formation of P29mtSAMP1 cybrids. However, current study showed
that tumor suppression was still observed in P29mt(sp)B6 cybrids
even in the absence of SAMP1 mtDNA (Fig. 1B). Moreover,
P29Hmt(b6)B6 but not P29Hmt(sp)B6 cybrids developed into tu-
mors (Fig. 2C), even though no substantial difference in the
amounts of ROS was observed between them (Fig. 3). Therefore,
Fig. 2. Effect of a nuclear DNA replacement in P29mt(sp)B6 cybrids with that from r0 P29H cells on tumor formation. (A) B6 mtDNA but not SAMP1 mtDNA is present in
P29Hmt(sp)B6 cybrids. The absence of mtDNA in r0 P29H cells was conﬁrmed by the absence of its PCR products. The presence of a 194-bp fragment resistant to EagI digestion in all
cybrids shows that they have B6 mtDNA but not SAMP1 mtDNA. (B) Nuclear DNA with the integrated Hyg-R plasmid is present in P29Hmt(b6)B6 and P29Hmt(sp)B6 cybrids.
Products of PCR with primer sets amplifying the integrated Hyg-R plasmid show that these cybrids and r0 P29H cells, but not P29mt(b6)B6 or P29mt(sp)B6, have r0 P29H nuclear
DNA. (C) P29Hmt(sp)B6 cybrids do not form tumors. Cells (5  106) were inoculated under the skin of B6 mice. No tumors were formed by P29Hmt(sp)B6 cybrids for up to 3 months,
even though they did not have SAMP1 mtDNA or P29 nuclear DNA with potentially integrated SAMP1 mtDNA fragments. In contrast, P29Hmt(b6)B6 cybrids formed tumors within
10 days after inoculation.
Fig. 3. Levels of mitochondrial ROS (superoxide) in P29Hmt(b6)B6 and P29Hmt(sp)
B6 cybrids. P29mtB6 cybrids were used as a negative control and P29mtSAMP1 as a
positive control. Relative superoxide levels are expressed as mean ﬂuorescence in-
tensity of MitoSOX-Red normalized to that in the negative control. Experiments were
performed in triplicate; error bars, ± S.D. **P < 0.01.
Table 3
Mapping of the PCR products of P29Hmt(sp)B6 cybrids ampliﬁed by using 16S rRNA-
primer pair with the sequence universally conserved among prokaryotes.
No. of PCR products Matched sequence by BLAST Accession No.
Species Chromosome
1 M. musculus 17 LC145625
2 M. musculus 17 LC145626
A. Shimizu et al. / Biochemical and Biophysical Research Communications 493 (2017) 252e257256ROS overproduction induced by SAMP1 mtDNA is not responsible
for tumor suppression, and some heritable cytoplasmic elements
other than mtDNA derived from SAMP1 mice might be present in
P29Hmt(sp)B6 cybrids and suppress their ability to form tumors
(Fig. S2).
We also excluded involvement of cytozoic bacteria derived from
SAMP1 mice as heritable cytoplasmic elements other than mtDNA
in tumor suppression (Table 3). However, some cytozoic bacteria
that could not be detected by our procedure might be present andresponsible for the tumor suppression. Moreover, endogenous
retroviruses might also function as such heritable cytoplasmic
factors and be responsible for the recognition of P29mtSAMP1,
P29mt(sp)B6, and P29Hmt(sp)B6 cybrids by innate immune cells,
resulting in suppression of tumor formation in B6 mice. In fact,
mouse strains contain various endogenous retroviruses in their
nuclear DNA, and some of them are infectious [26]. Although
mammalian cells are known to possess no heritable cytoplasmic
elements other than mtDNA, our current study warrants further
examination of whether some cytozoic bacteria or endogenous
retroviruses derived from SAMP1 mice function as such elements.Author contributions
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